Inhibition of the MerTK in combination with anti-PD-1 antibody and stereotactic RT (3x12 Gy) significantly delayed tumor growth of non-irradiated lesions and reduced numbers of lung metastases in mice with bilateral lung adenocarcinoma xenografts. Here, PDCD1 is linked to neoplasm.